Sudan Journal of Medical Sciences

Published date: Oct 16 2025

Journal Title: Sudan Journal of Medical Sciences

Issue title: Sudan JMS: Volume 20 (2025), Issue No. 3

Pages: 326 - 334

DOI: 10.18502/sjms.v20i3.18835

Kanwal Ashiqkanwal.ashiq@superior.edu.pkPunjab University College of Pharmacy (PUCP), University of the Punjab, Lahore

Naureen Shehzadinaureen.pharmacy@pu.edu.pkPunjab University College of Pharmacy (PUCP), University of the Punjab, Lahore

Muhammad Tanveer Khancompetant_pharmacist05@yahoo.comDepartment of Pharmacy, Lahore College for Women University (LCWU), Lahore

Khalid Hussainhussain_761@yahoo.comFaculty of Pharmacy, University of Lahore (UoL)

Background: Carica papaya is a tropical herb used traditionally for multiple medicinal uses. Its phytochemical compounds, like flavonoids and alkaloids, are antioxidant and anti-inflammatory in nature. The existing evidence indicates its possible involvement in cardiovascular health, especially in the control of hypertension. The objective of the current commentary is to highlight the dual therapeutic significance of C. papaya in the prevention and management of inflammation and hypertension.

Methods: This narrative review summarizes preclinical and clinical research on C. papaya. A targeted literature search (2000–2024) identified seven relevant studies on C. papaya in relation to hypertension and inflammation, which were included to support this commentary. Information was gathered from PubMed, Scopus, and Google Scholar, highlighting its antihypertensive and anti-inflammatory activity. Underlying mechanisms, such as antioxidant modulation and Angiotensin-converting enzyme (ACE) inhibition, were examined critically.

Results: Research indicates that C. papaya extracts decrease inflammatory markers and enhance vascular function. Animal models exhibit marked decreases in blood pressure and oxidative stress levels. The reported beneficial effects demonstrated that papaya may exert these effects through multiple mechanisms, such as the modulation of inflammatory pathways, augmentation of antioxidant defence, and direct vasodilation. Limited clinical trials have indicated favorable results, which justify further research.

Conclusion: C. papaya is a promising natural adjunct to inflammation and hypertension management. Its phytochemical complexity underlies its therapeutic effects through several mechanisms. Human studies are required to establish its efficacy and standardized dosing.

Keywords: Carica papaya, medicinal plants, inflammation, hypertension

[1] Koul, B., Pudhuvai, B., Sharma, C., Kumar, A., Sharma, V., Yadav, D., & Jin, J. O. (2022). Carica papaya L.: A tropical fruit with benefits beyond the tropics. Diversity, 14(8), 683. https://doi.org/10.3390/d14080683

[2] Vij, T., & Prashar, Y. (2015). A review on medicinal properties of Carica papaya Linn. Asian Pacific Journal of Tropical Disease, 5(1), 1–6. https://doi.org/10.1016/S2222-1808(14)60617-4

[3] Sadia, S., Tariq, A., Shaheen, S., Malik, K., Ahmad, M., Qureshi, H., & Nayyar, B. G. (2018). Ethnopharmacological profile of anti-arthritic plants of Asia—A systematic review. Journal of Herbal Medicine, 13, 8–25. https://doi.org/10.1016/j.hermed.2018.08.003

[4] Mahender, T., Sreeja, A. S., Anvesh, M., Ramakrishna, D., & Meghana, M. (2020). Ethnobotanical survey of medicinal plants used in the treatment of urolithiasis in Warangal Rural, Telangana, India. World Journal of Pharmaceutical Research, 9(4), 427–437.

[5] Kapoor, B., Kaur, G., Gupta, M., & Gupta, R. (2017). Indian medicinal plants useful in treatment of gout: A review for current status and future prospective. Asian Journal of Pharmaceutical and Clinical Research, 10(11), 407–416. http://dx.doi.org/10.22159/ajpcr.2017.v10i11.20170

[6] Babalola, B. A., Akinwande, A. I., Otunba, A. A., Adebami, G. E., Babalola, O., & Nwufo, C. (2024). Therapeutic benefits of Carica papaya: A review on its pharmacological activities and characterization of papain. Arabian Journal of Chemistry, 17(1), 105369. https://doi.org/10.1016/j.arabjc.2023.105369

[7] Zhou, B., Perel, P., Mensah, G. A., & Ezzati, M. (2021). Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nature Reviews Cardiology, 18(11), 785-802. https://doi.org/10.1038/s41569-021-00559- 8

[8] Zhang, Z., Zhao, L., Zhou, X., Meng, X., & Zhou, X. (2023). Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets. Frontiers in Immunology, 13, 1098725. https://doi.org/10.3389/fimmu.2022.1098725

[9] Ashiq, K., Ashiq, S., Shehzadi, N., Hussain, K., & Khan, M. T. (2022). Prevalence and control of the hypertension in patients suffering from rheumatoid arthritis. Pakistan Heart Journal, 55(4), 421–422. https://doi.org/10.47144/phj.v55i4.2352

[10] Theofilis, P., Sagris, M., Oikonomou, E., Antonopoulos, A. S., Siasos, G., Tsioufis, C., & Tousoulis, D. (2021). Inflammatory mechanisms contributing to endothelial dysfunction. Biomedicines, 9(7), 781. https://doi.org/10.3390/biomedicines9070781

[11] Plante, T. B., Juraschek, S. P., Howard, G., Howard, V. J., Tracy, R. P., Olson, N. C., & Cushman, M. (2024). Cytokines, C-reactive protein, and risk of incident hypertension in the REGARDS study. Hypertension, 81(6), 1244–1253. https://doi.org/10. 1161/HYPERTENSIONAHA.123.22714

[12] Ray, A., Maharana, K. C., Meenakshi, S., & Singh, S. (2023). Endothelial dysfunction and its relation in different disorders: Recent update. Health Sciences Review, 7, 100084. https://doi.org/10.1016/j.hsr.2023.100084

[13] Abbas, F., Rashid, A., Raza, S. A., Haq, M. I. U., Haider, S., & Ahmed, K. (2024). A comparative study of extraction optimization, antioxidant potential, and fatty acid composition of cucumis sativus and cucumis melo. International Journal of Pharmacy and Integrated Health Sciences, 5(2), 125–135. https://doi.org/10.56536/ijpihs.v5i2.169

[14] Siddique, S., Nawaz, S., Muhammad, F., Akhtar, B., & Aslam, B. (2018). Phytochemical screening and in-vitro evaluation of pharmacological activities of peels of Musa sapientum and Carica papaya fruit. Natural product research, 32(11), 1333–1336. https://doi.org/10.1080/14786419.2017.1342089

[15] Jarisarapurin, W., Kunchana, K., Chularojmontri, L., & Wattanapitayakul, S. K. (2021). Unripe Carica papaya protects methylglyoxal-invoked endothelial cell inflammation and apoptosis via the suppression of oxidative stress and Akt/MAPK/NF-κB signals. Antioxidants, 10(8), 1158. https://doi.org/10.3390/antiox10081158

[16] Kamilla, L., Tumpuk, S., & Salim, M. (2021). Anti-inflammatory of papaya leaf extract (Carica papaya L) towards membrane stabilization of red blood cells. Jurnal Kesehatan Prima, 15(1), 1–7. https://doi.org/10.32807/jkp.v15i1.399

[17] Shaban, N. Z., El-Kot, S. M., Awad, O. M., Hafez, A. M., & Fouad, G. M. (2021). The antioxidant and antiinflammatory effects of Carica Papaya Linn. seeds extract on CCl 4-induced liver injury in male rats. BMC Complementary Medicine and Therapies, 21, 1–15. https://doi.org/10.1186/s12906-021-03479-9

[18] Jarisarapurin, W., Sanrattana, W., Chularojmontri, L., Kunchana, K., & Wattanapitayakul, S. K. (2019). Antioxidant properties of unripe Carica papaya fruit extract and its protective effects against endothelial oxidative stress. Evidence-Based Complementary and Alternative Medicine, 2019(1), 4912631. https://doi.org/10.1155/2019/4912631

[19] Owoyele, B. V., Adebukola, O. M., Funmilayo, A. A., & Soladoye, A. O. (2008). Anti-inflammatory activities of ethanolic extract of Carica papaya leaves. Inflammopharmacology, 16(4), 168–173. https://doi.org/10.1007/s10787-008-7008-0

[20] Adedapo, A. A., & Orherhe, V. E. (2013). Antinociceptive and anti-inflammatory studies of the aqueous leaf extract of Carica papaya in laboratory animals. Asian Journal of Experimental Biological Sciences, 4(1), 89–96.

[21] Amazu, L. U., Azikiwe, C. C., Njoku, C. J., Osuala, F. N., Nwosu, P. J., Ajugwo, A. O., & Enye, J. C. (2010). Anti-inflammatory activity of the methanolic extract of the seeds of Carica papaya in experimental animals. Asian Pacific Journal of Tropical Medicine, 3(11), 884–886. https://doi.org/10.1016/S1995-7645(10)60212-X

[22] Ahmed, M. Z., & Ramabhimalah, S. (2015). Antiinflammatory activity of aqueous extract of Carica papaya seeds in albino rats. Biomedical and Pharmacology Journal, 5(1), 173–177.

[23] Eno, A. E., Owo, O. I., Itam, E. H., & Konya, R. S. (2000). Blood pressure depression by the fruit juice of Carica papaya (L.) in renal and DOCA-induced hypertension in the rat. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 14(4), 235–239. https://doi.org/10.1002/1099- 1573(200006)14:4%3C235::AIDPTR574% 3E3.0.CO;2-G

[24] Brasil, G. A., Ronchi, S. N., do Nascimento, A. M., de Lima, E. M., Rom ao, W., da Costa, H. B., Scherer, R., Ventura, J. A., Lenz, D., Bissoli, N. S., & Endringer, D. C. (2014). Antihypertensive effect of Carica papaya via a reduction in ACE activity and improved baroreflex. Planta Medica, 80(17), 1580– 1587. https://doi.org/10.1055/s-0034-1383122

[25] Lorenzetti, A., Osato, M., He, F., Aperio, C., Ayala, A., Rasulova, S., & Barbagallo, M. (2023). Interim report from a 2-year double-blind RCT testing fermented papaya preparation on immune enhancement, endothelial health and QoL in elderly adults. Functional Foods in Health and Disease, 13(2), 69– 81. https://doi.org/10.31989/ffhd.v13i2.1050

[26] Pratiwi, S. N., Nissa, C., Syauqi, A., Wijayanti, H. S., & Afifah, D. N. (2017, October 27–28). Effect of papaya leaves jelly on reducing blood pressure in prediabetic women [Conference presentation]. Proceedings of the International Conference on Translational Medicine and Health Sciences, Indonesia. https://docpak. undip.ac.id/id/eprint/49/1/C26-Artikel.pdf

[27] Hasimun, P., Sulaeman, A., & Maharani, I. D. P. (2020). Supplementation of Carica papaya leaves (Carica papaya L.) in nori preparation reduced blood pressure and arterial stiffness on hypertensive animal model. Journal of Young Pharmacists, 12(1), 63. https://dx.doi.org/10.5530/jyp.2020.12.12

[28] do Prado, S. B. R., Minguzzi, B. T., Hoffmann, C., & Fabi, J. P. (2021). Modulation of human gut microbiota by dietary fibers from unripe and ripe papayas: Distinct polysaccharide degradation using a colonic in vitro fermentation model. Food Chemistry, 348, 129071. https://doi.org/10.1016/j.foodchem.2021.129071